Please log in to view this page
Username
Password
Study Objective: Compare longitudinal HIV-1 antibody responses among HIV-1 infected participants that either did or did not...
The study is being done with people who are taking their first anti-HIV drug regimen (including an Non-Nucleoside Reverse...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
This is a Phase I, multi-site, open-label, non-comparative study of the PK, safety, tolerability, and acceptability of a...
We will address our hypothesis using a case-control study design. We plan to leverage the existing biorepository of...
